Advanced search
Publication Cover
Acta Oto-Laryngologica Volume 137, 2017 - Issue 6
Submit an article Journal homepage
123
Views
5
CrossRef citations to date
0
Altmetric
Research Article

PKCα promotes local advancement via its dual roles in nasopharyngeal carcinoma

Jing ZhangDepartment of Oncology, Xiangya Hospital, Central South University, Changsha, PR China; View further author information
,
Ying WangDepartment of Oncology, Xiangya Hospital, Central South University, Changsha, PR China; View further author information
,
Yumei DuanDepartment of Pathology, Xiangya Hospital, Central South University, Changsha, PR China; View further author information
,
Dan FanDepartment of Oncology, Xiangya Hospital, Central South University, Changsha, PR China; View further author information
,
Zhijiao ZhouDepartment of Pathology, The Third Xiangya Hospital, Central South University, Changsha, PR China; View further author information
,
Jianghai HuangDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, PR ChinaView further author information
,
Rui WeiDepartment of Oncology, Xiangya Hospital, Central South University, Changsha, PR China; View further author information
&
Liangfang ShenDepartment of Oncology, Xiangya Hospital, Central South University, Changsha, PR China; Correspondence[email protected]
View further author information
 show all
Pages 662-667 | Received 27 Sep 2016, Accepted 12 Nov 2016, Published online: 13 Jan 2017

References

  • Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet 2005;365:2041–54.
  • Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016;66:115–32.
  • Lee AW, Ma BB, Ng WT, Chan AT. Management of nasopharyngeal carcinoma: current practice and future perspective. J Clin Oncol 2015;33:3356–64.
  • Chua ML, Wee JT, Hui EP, Chan AT. Nasopharyngeal carcinoma. Lancet 2016;387:1012–24.
  • Wan XB, Fan XJ, Huang PY, Dong D, Zhang Y, Chen MY, et al. Aurora-A activation, correlated with hypoxia-inducible factor-1alpha, promotes radiochemoresistance and predicts poor outcome for nasopharyngeal carcinoma. Cancer Sci 2012;103:1586–94.
  • Luo XL, Zhong GZ, Hu LY, Chen J, Liang Y, Chen QY, et al. Serum apolipoprotein A-I is a novel prognostic indicator for non-metastatic nasopharyngeal carcinoma. Oncotarget 2015;6:44037–48.
  • Kang JH, Asai D, Toita R, Kitazaki H, Katayama Y. Plasma protein kinase C (PKC)alpha as a biomarker for the diagnosis of cancers. Carcinogenesis 2009;30:1927–31.
  • Antal CE, Hudson AM, Kang E, Zanca C, Wirth C, Stephenson NL, et al. Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor. Cell 2015;160:489–502.
  • Pu YS, Huang CY, Chen JY, Kang WY, Lin YC, Shiu YS, et al. Down-regulation of PKCζ in renal cell carcinoma and its clinicopathological implications. J Biomed Sci 2012;19:39.
  • Oster H, Leitges M. Protein kinase C alpha but not PKCzeta suppresses intestinal tumor formation in ApcMin/+ mice. Cancer Res 2006;66:6955–63.
  • Galvez AS, Duran A, Linares JF, Pathrose P, Castilla EA, Abu-Baker S, et al. Protein kinase Czeta represses the interleukin-6 promoter and impairs tumorigenesis in vivo. Mol Cell Biol 2009;29:104–15.
  • Kang M, Long J, Li G, Yan H, Feng G, Liu M, et al. A new staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy: results of a prospective multicentric clinical study. Oncotarget 2016;7:15252–61.
  • Lan M, Huang Y, Chen CY, Han F, Wu SX, Tian L, et al. Prognostic value of cervical nodal necrosis in nasopharyngeal carcinoma: analysis of 1800 patients with positive cervical nodal metastasis at MR imaging. Radiology 2015;276:536–44.
  • Rosse C, Linch M, Kermorgant S, Cameron AJ, Boeckeler K, Parker PJ. PKC and the control of localized signal dynamics. Nat Rev Mol Cell Biol 2010;11:103–12.
  • Larsson C. Protein kinase C and the regulation of the actin cytoskeleton. Cell Signal 2006;18:276–84.
  • Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003;4:915–25.
  • El-Gamal D, Williams K, LaFollette TD, Cannon M, Blachly JS, Zhong Y, et al. PKC-β as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL. Blood 2014;124:1481–91.
  • Wu X, Li J, Zhu M, Fletcher JA, Hodi FS. Protein kinase C inhibitor AEB071 targets ocular melanoma harboring GNAQ mutations via effects on the PKC/Erk1/2 and PKC/NF-kappaB pathways. Mol Cancer Ther 2012;11:1905–14.
  • Mackay HJ, Twelves CJ. Targeting the protein kinase C family: are we there yet? Nat Rev Cancer 2007;7:554–62.
  • Zhang LL, Cao FF, Wang Y, Meng FL, Zhang Y, Zhong DS, et al. The protein kinase C (PKC) inhibitors combined with chemotherapy in the treatment of advanced non-small cell lung cancer: meta-analysis of randomized controlled trials. Clin Transl Oncol 2015;17:371–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.